Reply to 'optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension'
- PMID: 38690910
- DOI: 10.1097/HJH.0000000000003724
Reply to 'optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension'
Comment on
-
Optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension.J Hypertens. 2024 Jun 1;42(6):1105-1106. doi: 10.1097/HJH.0000000000003691. Epub 2024 May 1. J Hypertens. 2024. PMID: 38690909 No abstract available.
References
-
- Peeters LEJ, Kappers MHW, Boersma E, Massey EK, van Dijk L, van Gelder T, et al. The effect of combining therapeutic drug monitoring of antihypertensive drugs with personalised feedback on adherence and resistant hypertension: the (RHYME-RCT) trial protocol of a multicentre randomised controlled trial. BMC Cardiovasc Disord 2023; 23:87.
-
- Peeters LEJ, Kappers MHW, Hesselink DA, van der Net JB, Hartong SCC, van de Laar R, et al. Antihypertensive drug concentration measurement combined with personalized feedback in resistant hypertension: a randomized controlled trial. J Hypertens 2024; 42:169–178.
-
- Gavrilova A, Bandere D, Rutkovska I, Šmits D, Mauriņa B, Poplavska E, et al. Knowledge about disease, medication therapy, and related medication adherence levels among patients with hypertension. Medicina (Kaunas) 2019; 55:E715.
-
- Burnier M, Egan Brent M. Adherence in hypertension. Circ Res 2019; 124:1124–1140.
-
- Peeters LEJ, van der Net JB, Schoenmakers-Buis K, van der Meer IM, Massey EK, van Dijk L, et al. Introducing the importance and difficulties of a three-step approach to improve nonadherence to antihypertensive drugs: a case series. J Hypertens 2022; 40:189–193.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
